Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to CO96051300ApriorityCriticalpatent/CO4770971A1/en
Publication of CO4770971A1publicationCriticalpatent/CO4770971A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de la fórmula (I)y derivados farmacéuticamente aceptables de los mismos, caracterizados porque Ro representa halógeno; R1 y R2 se seleccionan independientemente de H, halógeno, C1-4 alquilo, C1-4 alquilo sustituido por uno o más átomos de flúor, C1-4 alcoxi, C1-4 hidroxialquilo, SC1-4 alqui]o, C(O)H o C(O)C1-4 alquilo; y R3 representa C1-4 alquilo.Compounds of formula (I) and pharmaceutically acceptable derivatives thereof, characterized in that Ro represents halogen; R1 and R2 are independently selected from H, halogen, C1-4alkyl, C1-4alkyl substituted by one or more fluorine atoms, C1-4alkoxy, C1-4 hydroxyalkyl, SC1-4alk] or, C (O) H or C (O) C1-4 alkyl; and R3 represents C1-4 alkyl.